According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
A number of other research firms also recently issued reports on HYH. Stifel Nicolaus upped their price target on shares of Halyard Health from $38.00 to $45.00 and gave the company a buy rating in a research note on Tuesday, February 28th. JMP Securities downgraded shares of Halyard Health from an outperform rating to a market perform rating and set a $38.00 price target on the stock. in a research note on Friday, January 6th. Stephens downgraded shares of Halyard Health from an overweight rating to an equal weight rating in a research note on Tuesday, February 28th. Finally, Deutsche Bank AG downgraded shares of Halyard Health from a buy rating to a hold rating and set a $35.00 price target on the stock. in a research note on Thursday, December 15th. Five investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of $39.75.
Shares of Halyard Health (NYSE:HYH) opened at 37.87 on Wednesday. The stock’s 50 day moving average is $39.73 and its 200-day moving average is $36.96. The company has a market cap of $1.77 billion, a price-to-earnings ratio of 44.55 and a beta of 1.87. Halyard Health has a 52 week low of $26.05 and a 52 week high of $41.84.
Halyard Health (NYSE:HYH) last released its quarterly earnings results on Monday, February 27th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.06. The company had revenue of $410 million for the quarter, compared to the consensus estimate of $401.72 million. Halyard Health had a net margin of 2.80% and a return on equity of 8.63%. Halyard Health’s revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.57 earnings per share. On average, equities analysts anticipate that Halyard Health will post $1.84 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “Halyard Health Inc (HYH) Lifted to “Hold” at Zacks Investment Research” was first reported by Mideast Time and is the sole property of of Mideast Time. If you are viewing this piece on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this piece can be viewed at https://www.mideasttime.com/halyard-health-inc-hyh-lifted-to-hold-at-zacks-investment-research/1589202.html.
A number of large investors have recently added to or reduced their stakes in HYH. BlackRock Fund Advisors increased its stake in Halyard Health by 6.1% in the third quarter. BlackRock Fund Advisors now owns 2,512,061 shares of the company’s stock worth $87,068,000 after buying an additional 143,919 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Halyard Health by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,210,051 shares of the company’s stock worth $81,729,000 after buying an additional 330,186 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its stake in Halyard Health by 4.1% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 1,454,567 shares of the company’s stock worth $50,415,000 after buying an additional 56,792 shares during the last quarter. Panagora Asset Management Inc. increased its stake in Halyard Health by 103.2% in the third quarter. Panagora Asset Management Inc. now owns 770,426 shares of the company’s stock worth $26,703,000 after buying an additional 391,232 shares during the last quarter. Finally, Prudential Financial Inc. increased its stake in Halyard Health by 2.8% in the third quarter. Prudential Financial Inc. now owns 675,959 shares of the company’s stock worth $23,428,000 after buying an additional 18,674 shares during the last quarter. 87.50% of the stock is currently owned by institutional investors.
About Halyard Health
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Halyard Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.